Barlesi F - Search Results

1

Like a Rolling Stone: Sting-Cgas Pathway and Cell-Free DNA as Biomarkers for Combinatorial Immunotherapy.

Sicard G, Fina F, Fanciullino R, Barlesi F, Ciccolini J. Sicard G, et al. Among authors: barlesi f. Pharmaceutics. 2020 Aug 11;12(8):758. doi: 10.3390/pharmaceutics12080758. Pharmaceutics. 2020. PMID: 32796670 Free PMC article. Review.

2

Non-small cell lung cancer-smokers or non-smokers, does it matter?

Barlési F, Nanni-Metellus I, Breen D, Fina F, Astoul P, Martin PM. Barlési F, et al. Lung Cancer. 2009 Mar;63(3):430-2. doi: 10.1016/j.lungcan.2008.08.001. Epub 2008 Sep 11. Lung Cancer. 2009. PMID: 18789554

3

[Regional molecular genetics centers in thoracic oncology: what and who should be tested?].

Barlesi F, Tomasini P, Fina F, Secq V, Greillier L, Nanni-Metellus I, Garcia S, Ouafik L. Barlesi F, et al. Bull Cancer. 2013 Jul-Aug;100(7-8):737-41. doi: 10.1684/bdc.2013.1774. Bull Cancer. 2013. PMID: 23823903 French.

4

Metronomics chemotherapy: time for computational decision support.

Barbolosi D, Ciccolini J, Meille C, Elharrar X, Faivre C, Lacarelle B, André N, Barlesi F. Barbolosi D, et al. Among authors: barlesi f. Cancer Chemother Pharmacol. 2014 Sep;74(3):647-52. doi: 10.1007/s00280-014-2546-1. Epub 2014 Aug 1. Cancer Chemother Pharmacol. 2014. PMID: 25082520 Review.

5

Ang1 and Tie2 are predictive biomarkers for bevacizumab-letter.

Ciccolini J, Serdjebi C, Barbolosi D, Lacarelle B, Barlesi F. Ciccolini J, et al. Among authors: barlesi f. Clin Cancer Res. 2015 Feb 15;21(4):934. doi: 10.1158/1078-0432.CCR-14-2832. Clin Cancer Res. 2015. PMID: 25691775 No abstract available.

6

Improving efficacy of the combination between antiangiogenic and chemotherapy: Time for mathematical modeling support.

Ciccolini J, Benzekry S, Lacarelle B, Barbolosi D, Barlési F. Ciccolini J, et al. Among authors: barlesi f. Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):E3453. doi: 10.1073/pnas.1506689112. Epub 2015 Jun 16. Proc Natl Acad Sci U S A. 2015. PMID: 26080431 Free PMC article. No abstract available.

7

Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine.

Benzekry S, Pasquier E, Barbolosi D, Lacarelle B, Barlési F, André N, Ciccolini J. Benzekry S, et al. Among authors: barlesi f. Semin Cancer Biol. 2015 Dec;35:53-61. doi: 10.1016/j.semcancer.2015.09.002. Epub 2015 Sep 7. Semin Cancer Biol. 2015. PMID: 26361213 Review.

8

Rs488087 single nucleotide polymorphism as predictive risk factor for pancreatic cancers.

Martinez E, Silvy F, Fina F, Bartoli M, Krahn M, Barlesi F, Figarella-Branger D, Iovanna J, Laugier R, Ouaissi M, Lombardo D, Mas E. Martinez E, et al. Among authors: barlesi f. Oncotarget. 2015 Nov 24;6(37):39855-64. doi: 10.18632/oncotarget.5627. Oncotarget. 2015. PMID: 26498142 Free PMC article.

9

Computational oncology--mathematical modelling of drug regimens for precision medicine.

Barbolosi D, Ciccolini J, Lacarelle B, Barlési F, André N. Barbolosi D, et al. Among authors: barlesi f. Nat Rev Clin Oncol. 2016 Apr;13(4):242-54. doi: 10.1038/nrclinonc.2015.204. Epub 2015 Nov 24. Nat Rev Clin Oncol. 2016. PMID: 26598946 Review.

10

[Oncogenic drivers in daily practice improve overall survival in patients with lung adenocarcinoma].

Fournier C, Greillier L, Fina F, Secq V, Nanni-Metellus I, Loundou A, Garcia S, Ouafik L, Tomasini P, Barlesi F. Fournier C, et al. Among authors: barlesi f. Rev Mal Respir. 2016 Nov;33(9):751-756. doi: 10.1016/j.rmr.2015.12.009. Epub 2016 Mar 24. Rev Mal Respir. 2016. PMID: 27017063 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

458 results

Search Page